- Report
- March 2024
- 147 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- November 2024
- 650 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- November 2024
- 350 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- March 2025
- 650 Pages
Global
From €6676EUR$6,995USD£5,593GBP
- Report
- September 2024
- 106 Pages
Global
From €4724EUR$4,950USD£3,958GBP
€5249EUR$5,500USD£4,398GBP
- Report
- March 2025
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 199 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- June 2024
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 197 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 411 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- December 2024
- 251 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2024
- 128 Pages
Europe
From €3818EUR$4,000USD£3,199GBP
- Report
- December 2024
- 151 Pages
Middle East, Africa
From €3293EUR$3,450USD£2,759GBP
- Report
- June 2024
- 108 Pages
Europe
From €3293EUR$3,450USD£2,759GBP

The Genomic Medicine market is a rapidly growing sector of the genomics industry. It focuses on the development and application of genomic technologies to improve healthcare outcomes. This includes the use of genomic sequencing to diagnose and treat diseases, as well as the development of personalized treatments based on a patient's genetic profile. Genomic Medicine also involves the use of bioinformatics to analyze and interpret genomic data, and the development of new technologies to enable the use of genomic data in clinical practice.
The Genomic Medicine market is driven by the increasing availability of genomic data, advances in sequencing technologies, and the growing demand for personalized healthcare. It is expected to continue to grow in the coming years, as more healthcare providers adopt genomic technologies and the use of genomic data becomes more widespread.
Some companies in the Genomic Medicine market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more